Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
6.56M
-
Shares change
-
+249K
-
Total reported value, excl. options
-
$43.2M
-
Value change
-
+$1.61M
-
Number of buys
-
11
-
Number of sells
-
-1
-
Price
-
$6.48
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2022
16 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2022.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.56M shares
of 71.9M outstanding shares and own 9.12% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5.9M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), Yorktown Management & Research Co Inc (74.9K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.6K shares), UBS Group AG (9.1K shares), MORGAN STANLEY (3.84K shares), and JPMORGAN CHASE & CO (3K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.